Evidence map›Paper›PMID 36143487›Full record

ArticleLife (Basel, Switzerland)2022

Mónica A Valdez-Solana, Iván A Corral-Guerrero, Alfredo Téllez-Valencia, Claudia Avitia-Domínguez, Jorge A Meza-Velázquez, Atahualpa Guzmán de Casa, Erick Sierra-Campos

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. The GenusLife (Basel, Switzerland) · 2025
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mónica A Valdez-SolanaFacultad de Ciencias Químicas GP, Universidad Juárez del Estado de Durango, Av. Artículo 123 S/N Fracc. Filadelfia, Gómez Palacio 35015, Mexico.
Iván A Corral-GuerreroFacultad de Ciencias Químicas GP, Universidad Juárez del Estado de Durango, Av. Artículo 123 S/N Fracc. Filadelfia, Gómez Palacio 35015, Mexico.
Alfredo Téllez-ValenciaFacultad de Medicina y Nutrición, Universidad Juárez del Estado de Durango, Av. Universidad y Fanny Anitúa S/N, Durango 34000, Mexico.ORCID 0000-0001-7629-4111
Claudia Avitia-DomínguezFacultad de Medicina y Nutrición, Universidad Juárez del Estado de Durango, Av. Universidad y Fanny Anitúa S/N, Durango 34000, Mexico.
Jorge A Meza-VelázquezFacultad de Ciencias Químicas GP, Universidad Juárez del Estado de Durango, Av. Artículo 123 S/N Fracc. Filadelfia, Gómez Palacio 35015, Mexico.ORCID 0000-0003-0629-476X
Atahualpa Guzmán de CasaCentro de Investigación y Estudios Avanzados del IPN, Departamento de Biotecnología y Bioquímica, Km 9.6 Libramiento Norte Carretera Irapuato-León, Irapuato 36824, Mexico.
Erick Sierra-CamposFacultad de Ciencias Químicas GP, Universidad Juárez del Estado de Durango, Av. Artículo 123 S/N Fracc. Filadelfia, Gómez Palacio 35015, Mexico.ORCID 0000-0001-8622-4045

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most important therapeutic modalities for the management of hypertension is the inhibition of the angiotensin-converting enzyme (ACE).

Indexed as

angiotensin-converting enzymecordycepinCordyceps militarismolecular docking

Identifiers

PMID36143487
PMCPMC9505812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.